RxDoctor Payments Data

Charles Stokley, MD

Family Medicine · Waynesboro, MSNPI 1851488514

Payments from drug & device makers

$607in general payments, 2019–2025

Across 28 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$191
  • GSK$86
  • AstraZeneca$60
  • Novartis$50
  • Otsuka America Pharmaceutical, Inc.$41
  • Exact Sciences$40
  • plus $138 from 6 others

What the payments were for

  • Food & beverage$607100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$607 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$363,814
Medicare patients
654
Services billed
9,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide107$112,446
EliquisApixaban120$71,652
LinzessLinaclotide73$70,568
FarxigaDapagliflozin Propanediol80$65,749
MounjaroTirzepatide58$55,086
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$53,838
JardianceEmpagliflozin43$48,296
JanuviaSitagliptin Phosphate34$34,640
NuedextaDextromethorphan Hbr/Quinidine16$27,063
MyrbetriqMirabegron16$19,261
Tresiba Flextouch U-100Insulin Degludec13$9,670
JanumetSitagliptin Phos/Metformin Hcl17$9,025
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen416$7,959
EntrestoSacubitril/Valsartan12$7,849
SymbicortBudesonide/Formoterol Fumarate30$7,542

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$31$115,398125 claims
AstraZenecaFarxiga, Symbicort$60$73,291110 claims
AbbVieLinzess$191$70,56873 claims
Lilly USA, LLCMounjaro$22$55,08658 claims
GSKTrelegy Ellipta$86$53,83868 claims
Boehringer IngelheimJardiance$20$48,29643 claims
NovartisEntresto$50$7,84912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Waynesboro

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →